Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Kastelein

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Atherosclerosis|June 26, 1999
The future of best practiceJ J Kastelein
BMJ (Clinical Research Ed.)|December 16, 2000
Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractiveJ J Kastelein
Lancet (London, England)|December 16, 1998
Molecular epidemiology of familial hypercholesterolaemiaJ C Defesche, J J Kastelein
Annals of the New York Academy of Sciences|June 24, 2000
Tailored therapy to fit individual profiles. Genetics and coronary artery diseaseJ W Jukema, J J Kastelein
Nederlands Tijdschrift Voor Geneeskunde|March 2, 1996
[Favorable effects of hormone substitution therapy in the menopause on risk factors for ischemic heart disease]J J Kastelein, J V Hamerlynck
Nederlands Tijdschrift Voor Geneeskunde|April 13, 1991
[Low-density lipoprotein receptors]J J Kastelein, J W ten Cate
Nederlands Tijdschrift Voor Geneeskunde|April 12, 1997
[Familial combined hyperlipidemia]J J Kastelein, J W ten Cate
American Journal of Human Genetics|July 1, 1988
Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH)S Langlois, J J Kastelein, M R Hayden
Atherosclerosis|October 1, 1987
Insufficient evidence to invoke defects in or around the A-I gene as the cause for familial hypoalphalipoproteinemiaM R Hayden, J J Kastelein, S Langlois
Nederlands Tijdschrift Voor Geneeskunde|June 20, 1992
[Postmenopausal estrogen substitution and the risk of atherosclerotic heart and vascular diseases]E Dekker, H R Büller, J J Kastelein
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Atherosclerosis|June 26, 1999
The future of best practiceJ J Kastelein
BMJ (Clinical Research Ed.)|December 16, 2000
Screening for familial hypercholesterolaemia. Effective, safe treatments and dna testing make screening attractiveJ J Kastelein
Lancet (London, England)|December 16, 1998
Molecular epidemiology of familial hypercholesterolaemiaJ C Defesche, J J Kastelein
Annals of the New York Academy of Sciences|June 24, 2000
Tailored therapy to fit individual profiles. Genetics and coronary artery diseaseJ W Jukema, J J Kastelein
Nederlands Tijdschrift Voor Geneeskunde|March 2, 1996
[Favorable effects of hormone substitution therapy in the menopause on risk factors for ischemic heart disease]J J Kastelein, J V Hamerlynck
Nederlands Tijdschrift Voor Geneeskunde|April 13, 1991
[Low-density lipoprotein receptors]J J Kastelein, J W ten Cate
Nederlands Tijdschrift Voor Geneeskunde|April 12, 1997
[Familial combined hyperlipidemia]J J Kastelein, J W ten Cate
American Journal of Human Genetics|July 1, 1988
Characterization of six partial deletions in the low-density-lipoprotein (LDL) receptor gene causing familial hypercholesterolemia (FH)S Langlois, J J Kastelein, M R Hayden
Atherosclerosis|October 1, 1987
Insufficient evidence to invoke defects in or around the A-I gene as the cause for familial hypoalphalipoproteinemiaM R Hayden, J J Kastelein, S Langlois
Nederlands Tijdschrift Voor Geneeskunde|June 20, 1992
[Postmenopausal estrogen substitution and the risk of atherosclerotic heart and vascular diseases]E Dekker, H R Büller, J J Kastelein
Pageof 16